3sbio
3SBio Inc., a leading biopharmaceutical company headquartered in China, has established itself as a key player in the biotechnology industry since its founding in 1993. With a strong operational presence across major regions in Asia, 3SBio focuses on the development, manufacturing, and marketing of innovative therapies, particularly in the fields of oncology, nephrology, and autoimmune diseases. The company is renowned for its core products, including recombinant human erythropoietin and other biologics, which are distinguished by their high quality and efficacy. Over the years, 3SBio has achieved significant milestones, including successful product launches and strategic partnerships, solidifying its market position as a trusted provider of biopharmaceutical solutions. With a commitment to advancing healthcare, 3SBio continues to drive innovation and improve patient outcomes in the biopharmaceutical landscape.
DitchCarbon Score
How does 3sbio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
3sbio's score of 24 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
3sbio's reported carbon emissions
In 2023, 3sbio reported total carbon emissions of approximately 60,649,530 kg CO2e, with Scope 1 emissions at about 11,663,450 kg CO2e and Scope 2 emissions at approximately 48,986,080 kg CO2e. This marked an increase from 2022, where total emissions were about 45,896,560 kg CO2e. Over the years, 3sbio has shown fluctuations in its emissions, with total emissions recorded at approximately 48,685,270 kg CO2e in 2019, decreasing to about 47,720,880 kg CO2e in 2020, and then rising again to approximately 50,274,940 kg CO2e in 2021. The company has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for improvement in their climate commitments. Overall, while 3sbio has made strides in tracking its emissions, the lack of defined reduction targets suggests that further action may be necessary to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 5,960,680 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 2 | 42,724,590 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
3sbio is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
